Poorly soluble drugs are a major issue for the pharmaceutical industry. By using solubility enhancement excipients pharmaceutical formulators can increase the bioavailability of the active pharmaceutical ingredient (API). Advanced solubility enhancement excipients can help companies bring products to market faster. Developing pharmaceutical formulations with appropriate solubility will continue to be one of the key challenges of next years.
Your search returned 49 Excipient Search across 9 suppliers.
Select up to 5 products from below to compare or request more information.
Sponsored Products
- Functionality: Solubilizer, Emulsifier, Solvent
- Application: Inquire
- Functionality: Solubilizer
- Application: Inquire
- Functionality: Solubilizer, Binder
- Application: Spray Drying, Wet Granulation, Solubilization
- Functionality: Water disperible surfactant, solubilizer and bioavailability enhancer in SMEDDS, topical penetration/permeation enhancer, able to form light foams with pump device (no gas required), low impurities guaranteed for stability and capsule compatibility
- Application: Oral, Topical, Transdermal
- Functionality: Oily vehicle solubilizer and bioavailability enhancer for lipophilic APIs, associated with lymphatic absorption, oily vehicle for topical formulations
- Application: Oral, Topical
- Functionality: Solubilizer, Increased bioavailability, Stabilizer
- Application: Improves solubility, stability, bioavailability and dosing of APIs
- Functionality: Binder
- Application: Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.
- Functionality: Solubilizer
- Application: Nonionic emulsifier for O-W emulsions, Solubilizer
- Functionality: Solubilizer, Emulsifier, Solvent
- Application: Inquire
- Functionality: Solubilizer, Emulsifier
- Application: Inquire
- Functionality: Solubilizer
- Application: Inquire
- Functionality: Solubilizer
- Application: Inquire
- Functionality: Solubilizer, Emulsifier, Solvent
- Application: Inquire
- Functionality: Solubilizer
- Application: Inquire
- Functionality: Solubilizer
- Application: For sensitive active ingredients to improve their stability
- Functionality: Solubilizer
- Application: Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions
- Functionality: Solubilizer
- Application: Liquid plasticizer for tablet coatings, Solvent for APIs, dispersing agent, stabilizer and co-emulsifier in semi-solid formulations
- Functionality: Binder
- Application: Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)
- Functionality: Solubilizer, Emulsion Stabilizer
- Application: Inquire
- Functionality: Excipient, Surfactant, Self-Emulsifying Drug Delivery, Solbuilizer, Solvent
- Application: Inquire
- Functionality: Emulsifier, Solubilizer, Solvent
- Application: Inquire
- Functionality: Excipient, Penetration Enhancer, Self-Emulsifying Drug Delivery, Solubilizer, Solvent
- Application: Inquire
- Functionality: Excipient, Emulsifier, Surfactant, Self-Emulsifying Drug Delivery, Solubilizer
- Application: Inquire
- Functionality: Viscosity Modifier, Solvent, Solubilizer
- Application: Inquire
- Functionality: Excipient, Emulsifier, Plasticizer, Solubilizer, Wetting Agent
- Application: Inquire
- Functionality: Emulsifier, Plasticiser, Solubiliser
- Application: Inquire
- Functionality: Solubilizer, Emulsifier
- Application: Inquire
- Functionality: Solubilizer, Emulsifier, Surfactant
- Application: Inquire
- Functionality: Solubilizer, bioavailability and penetration enhancer, water insoluble W/O cosurfactant for SELF and suspensions
- Application: Oral, Topical
- Functionality: Solubilizer, bioavailability and penetration enhancer, water insoluble W/O cosurfactant for SELF and suspensions
- Application: Oral, Topical, Transdermal, Parenteral
- Functionality: Solubilizer, bioavailability enhancer, and surfactant in solid dispersions and SMEDDS
- Application: Oral
- Functionality: Solubilizer, bioavailability enhancer, and surfactant for poorly-soluble APIs, solid dispersions, and SMEDDS
- Application: Oral
- Functionality: Solubilizer, bioavailability enhancer, and surfactant for poorly-soluble APIs in solid dispersions and SMEDDS, lipid binder in melt processes
- Application: Oral
- Functionality: Oily phase vehicle and solubilizer
- Application: Oral, Topical
- Functionality: Oily phase vehicle and solubilizer
- Application: Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
- Functionality: Solubilizer and bioavailability enhancer for poorly-soluble APIs, self-emulsifier in aqueous fluid, co-emulsifier in topical formulations often associated with Tefose® 63
- Application: Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
- Functionality: Solubilizer and bioavailability enhancer for poorly-soluble APIs, self-emulsifier in aqueous fluid
- Application: Oral, Topical, Rectal/Vaginal, Transdermal, Nasal, Parenteral
- Functionality: Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer
- Application: Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Injectables, Topical Penetration and Permeation enhancer
- Functionality: Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid
- Application: Solubilizer, Bioavailability enhancer, Surfactant in capsule filling, SMEDDS, Solutions, Suspensions, Topical Penetration and Permeation enhancer, Processing aid
- Functionality: Solubilizer and O/W surfactant for microemulsion. Able to form light foams with pump device (no gas required).
- Application: Water dispersible surfactant, Solubilizer, Bioavailability enhancer, Component of SELF, Topical penetration/permeation enhancer
- Functionality: Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions
- Application: Oral, Topical, Transdermal
- Functionality: Solubilizer, bioavailability and penetration enhancer, water insoluble W/O co-surfactant for SELF and suspensions
- Application: Oral, Topical, Transdermal
- Functionality: Oily vehicle solubilizer and bioavailability enhancer for lipophilic APIs, associated with lymphatic absorption, oily vehicle for topical formulations
- Application: Oral, Topical
- Functionality: Solubilizer and bioavailability enhancer for poorly-soluble APIs, cosurfactant in microemulsions, viscosity enhancer for capsule filling
- Application: Oral, Topical
- Functionality: High purity solvent for all types of dosage forms, capsules, injectables, co-solvent in SMEDDS, solutions, suspensions, topical penetration and permeation enhancer
- Application: Oral, Topical, Transdermal, Parenteral
- Functionality: High purity solvent, topical penetration and permeation enhancer, co-solvent in SMEDDS, solutions, suspensions
- Application: Oral, Topical, Transdermal, Parenteral
- Functionality: Coating Systems, Viscosity Modifier, Solubilizer, Controlled Release, Binder, Emulsifier, Plasticizer
- Application: Inquire
Inquire
- Functionality: solubilizer, stabilizer and taste-making agent
- Application: Pharmaceutical and nutraceutical applications including swallowable tablets, chewable tablets, effervescent tablets, lozenges, hard capsules, soft capsules, coatings, orally dissolving films, blends, granules, pellets premix, medicated confectionary, syrups, suspensions, liquids, creams, paste and semi-solids.
- Functionality: improves drug solubility and stability against light or oxidation by molecular encapsulation
- Application: Encapsulating agent
Select up to 5 products from above to compare or request more information.
Tags:
Please Login or Register to Create Tags
Articles
- Understanding and Resolving Drug Shortages in the Pharmaceutical Industry
- Process Validation and Sterility Assurance: Relations and Requirements
- Pharmaceutical P.I.N. Points: Patent Innovation News - March 2023
- Keeping Patients in Focus: Limiting Treatment Burden for Improved Eye Care
- An Update on Oral Administration of Peptides to Achieve Systemic Delivery
- The Lifecycle of Drugs from Development to Approval and Market Launch
- Pharmaceutical P.I.N. Points: Patent Innovation News - April 2023
- Moving Towards Genome Integrity Evaluation of Gene Therapy Viral Vectors
- Principles of Drug Design: How to Leverage Ligand-Receptor Molecular Interactions
- Solid Lipid Nanocarrier Development Toolbox for Increasing Oral Bioavailability of API
- A Discourse on Pharmaceutical cGMP FDA Form 483 Trends: Why are We Re-Living the Same Issues Over the Last 23 Years?
- Modified Beta Cyclodextrin
- Enhancing Formulation Development: Leveraging Specialty Chemicals for Improved Drug Delivery
- Precision Medicine in Clinical Trials: A Statistical Perspective
- Viatel™ Bioresorbable Polymers with High Molecular Weight Formulation
- Viatel™ Ultrapure Bioresorbable Polymers
- Viatel Bioresorbable Polymers
- Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective
- Development of Freeze-dried Formulations Using Thermal Analysis and Microscopy
- Quality-by-Design for Freeze-Thaw of Biologics: Concepts and Application to Bottles of Drug Substance
- Application Challenges and Examples of New Excipients in Advanced Drug Delivery Systems
- Amorphous Solid Dispersions as Enabling Formulations for Discovery and Early Development
- Ion Chromatography in USP-NF
- Parenteral Products: Pharmacopeial Control of Containers, Storage and Distribution
- Evaluation of In-Situ Fiber Optics Dissolution Method for Compound A Extended Release Tablets
- Compendial Standards and Excipient Performance in the QbD Era: USP Excipient Performance Chapter <1059>
- Davisco Foods International, Inc. and Meggle Group announce a Joint Venture for the Production of Pharmaceutical Lactose
- Hot-stage Optical Microscopy as an Analytical Tool to Understand Solid-state Changes in Pharmaceutical Materials
- Advances in Lipid-based Formulations: Overcoming the Challenge of Low Bioavailability for Poorly Water Soluble Drug Compounds
- Mechanism of Stabilization of Proteins by Poly-hydroxy Co-solvents: Concepts and Implications in Formulation Development
- Miniaturized Equipment for Early Formulation Development
- Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
- In Vitro High-throughput Drug Precipitation Methods for Oral Formulations
- An Interview with DSM
- Why is GMP Training a Necessity at Excipient Sites?
- Stability Testing – Doing Everything or Doing the Right Thing?
- Aptalis Pharmaceutical Technologies Sponsors 2012 Controlled Release Society’s Young Investigator Award at Annual Meeting and Exposition
- Using Process Analytical Technologies for Real Time Monitoring and Quality Assurance in Chemical Development
- Functionality and Performance of Excipients in a Quality-by-Design World Part X: Continuous Processing of Pharmaceutical Finished Products
- Functionality and Performance of Excipients in a Quality-by-Design World, Part IX: New Excipients
- New VitalDose® Blog Debuts
- Functionality and Performance of Excipients in Quality-by-Design World, Part VIII: Excipient Specifications
- Functionality and Performance of Excipients in Quality-by-Design World, Part VII: Quality Risk Management
- Functionality and Performance of Excipients in Quality-by-Design World Part VI: Excipient Composition
- Catalent Announces Commencement of Supply of Abilify® Orally Disintegrating Tablets to Otsuka Pharmaceutical Co. Ltd. and Extensive Investments to it's Zydis® to Technology Capabilities in Swindon, UK
- Functionality and Performance of Excipients in Quality-by-Design World Part V: Changes in the Sourcing and Supply of Pharmaceutical Excipients
- An Interview with Meggle
- An Interview with DSM
- Use of Enzymes in the Dissolution Testing of Gelatin Capsules
- The Impact of USP’s New Elemental Impurities Standards on Manufacturers, Suppliers and Contract Laboratories
- BASF Extends Offer Period for Pronova BioPharma
- BASF Increases Cash Offer for Pronova BioPharma
- The Innovator Pipeline: Bioavailability Challenges and Advanced Oral Drug Delivery Opportunities
- BASF Starts Up tert. Butylamine plant in Nanjing, China
- CPhI opens Awards to Global Pharma Industry, Celebrating Tomorrow’s Innovations Today
- The Creation of an Excipient Properties Database to Support Quality by Design (QbD) Formulation Development
- Controlled Release Pulmonary Therapies: Promises and Concerns
- CPhI Report Indicates a Need for Greater Third Party Certification to Ensure GMP Vigilance
- Aesica Appoints Ian Muir to Newly Created Commercial Managing Director Position
- CPhI Announces USA Market Report at InformEx
- An Interview With Jasmine Musakhanian, M.Sc. Marketing & Scientific Director of Pharmaceutical Division Gattefossé USA
- CELPHERE MCC Spherical Seed Core
- CEOLUS KG Grade Microcrystalline Cellulose
- CEOLUS PH Grade Microcrystalline Cellulose
- CEOLUS UF Grade Microcrystalline Cellulose
- Soluplus
- Actimask® Acetaminophen 92M
- Lubrizol Invests $60 Million to Expand Particle Sciences, Vesta and Other Facilities in 2017
- Gattefossé North America Announces Recipient of 2017 Award for Excellence
- An Interview With Shaukat Ali, PhD
- ABITEC, UNIVAR Canada Announce Specialty Lipid Distribution Agreement
- Tracking Host Cell Proteins During Biopharmaceutical Manufacturing: Advanced Methodologies to Ensure High Product Quality
- Facility Tour: Gattefossé - The Lipid Chemistry Experts
- ABITEC Launches New Versatile Excipient for Oral Dosage Applications
- FDA Finalizes Bulk Drug substances Rule
- The CDMO’s Challenges for Developing Oral Suspensions for Children
- An Interview With... Dr. Egmont G. Pfeifer and Dr. Albrecht Krämer of MEGGLE Group
- Lipids in Transdermal and Topical Drug Delivery
- World’s First Triple Compound: CombiLac® from Meggle
- Taste Masking Techniques in the Pharmaceutical Industry
- Trends and Innovations in Oral Drug Delivery Round Table
- Roundtable: Excipient Trends/Challenges
- Forensics in QbD: Addressing Foreign Particulate Matter Investigations
- Hydroxypropyl Cellulose for Orally Disintegrating Film Drug Application
- Micromeritics to Participate in University of Maryland Tableting Course
- Natoli Debuts New Website
- First GMP-Compliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use
- Catalent Announces Two Senior Executive Appointments to Support Global Development and Clinical Services Business Growth
- Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand
- Almac Makes Further Significant co-investment to Meet Japanese Client Demand for Humidity Controlled Blister Packaging
- BASF and Colorcon Cooperate on Kollicoat® IR for Ready-to-Use Pharmaceutical Coating Solutions
- EMD Millipore Expands its EMPROVE® Raw Materials Portfolio to 400 Products
- Pharmaceutical Excipients Identification With Handheld Raman
- BASF to Build New World-scale Plant for Specialty Amines in Ludwigshafen
- Quotient Clinical Extends its Translational Pharmaceutics™ Platform into Cancer Drug Development
- Croda Celebrates EXCiPACTTM “Double”
- CPhI Pharma Awards Winners Showcase the Innovations Driving Pharma
- Thermo Fisher Scientific Receives Clearance from the European Commission for its Acquisition of Life Technologies
- CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
- Catalent Pharma Solutions and Adamas Pharmaceuticals Enter Into Phase 3 Clinical Trials Manufacturing Agreement for Potential New Treatment for Levodopa Induced Dyskinesia
- BASF Received EXCiPACTTM Certification as Pharmaceutical Excipient Supplier
- Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
- The Future of Pharmaceutical Excipients: A $14 Billion Market Driven by Global Demand
- Microbiologics Announces New CEO
- Particle Engineering For Improved Bioavailability In Oral Solid Dose Medications
- Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
- MEGGLE Appoints Barentz as its Exclusive Distributor of Pharmaceutical-Grade Lactose for United States
- Ginkgo Bioworks Announces Collaboration with Merck to Improve API Manufacturing
- Ashland Injectable Excipient Accepted Into FDA Novel Excipient Review Program
- Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems
- DFE Pharma Expands Co-Processed Portfolio
- Merck KGaA: Allergopharma Plans to Invest € 40 Million in Production Facility
- Expert Presentations at Australia Workshop on Powder Characterisation and Inhaler Testing
- CPhI Worldwide 2013 Hosted More Than 34,000 Global Pharma Professionals with Expanded Content and First Annual Report
- Vetter Launches New Clinical Syringe Packages
- The New Dawn of Pharmaceutical Manufacturing: Innovative Solutions for Unprecedented Challenges
- Colorcon, Inc. Launches First Certified Organic Coating System for Dietary Supplement Tablets
- Tergus Grows Manufacturing Capabilities Tergus Grows Manufacturing Capabilities
- Investigation of Excipient Compatibility and Associated Degradations for the Formulation Development of a Small Molecule Pharmaceutical Compound
- Rapid Detection of Counterfeit Drugs of Ethambutol Hydrochloride and Cefuroxime Axetil using Handheld Raman, Near Infrared and Portable FTIR Technologies
- Future of Transdermal Drug Delivery Systems (TDDS)
- Are HPLC-UV Methods Fit for Purpose as True Arbiters of Quality for APIs?
- A Recent Advancement in Orally Disintegrating Formulations
- BASF pharmaceutical solutions presented at CPhI Worldwide in Frankfurt, Germany
- API, Excipient, and Dosage Form Characterization Solutions for the Identity and Control of Critical Quality Attributes (CQA)
- Utilizing a Novel Disperser Technology to Accelerate Sample Extraction of Pharmaceutical Solid Dosage Forms
- Solid State Considerations for Early Development
- Crodasol HS HP
- “Joshi Capsules” US patent numbers – 8728521 and 9884024
- The KEY TO Pharma’s Next Generation Success
- The Evaluation of Dual Laser Handheld Raman Spectroscopy for Identifying Novel Psychoactive Substances
- Automated and Rapid Methods to Assess Quality & Stability of Biologics: Recent Developments and Practical Ways to Implement Them in Formulation Development
- Drug Delivery Roundtable
- Elemental Impurities: Implications for Manufacturers of Drug Products, APIs, and Excipients
- Theory of Sampling (TOS) for Development of Spectroscopic Calibration Models
- An Interview With Andreas Gryczke, Global Technical Marketing Solubilization BASF Pharma Solutions
- Raw Materials and Functional Excipients Roundtable
- Benefits of Using High-Functionality Excipients in a Continuous Manufacturing Process
- ABITEC Improves Solubility of Topical, Transdermal Applications with Functional Lipid Excipients
- Recent Innovations in Pharmaceutical Hot Melt Extrusion
- Johnson & Johnson Appoints Senior Leaders to Executive Committee
- CURE Pharmaceutical Debuts CUREform Drug Delivery Line
- ReForm Biologics, MilliporeSigma Announce Licensing Agreement
- Valneva and IDT Biologika Terminate their COVID-19 Collaboration
- New Pancreatic Cancer Drug Receives Orphan Drug Designation by FDA
- Roquette Acquires Qualicaps
- Antibody-Drug Conjugates (ADCs): Potent Cancer Killers with PK Challenges
- Pharmaceutical P.I.N. Points: Patent Innovation News
- Lubrizol Licenses Apisolex Excipient to Welton Pharmaceuticals to Develop Novel Cancer Therapeutic
- Reader Quiz: Drug Development Challenges
- Vibrational Spectroscopy for the Analysis of Dissolved Active Pharmaceutical Ingredients
- VITAMIN C – Tableting with LUBRITAB® RBW Lubricant
- Nanoparticle Technologies: Enablers for Ocular Drug Delivery
- Pharmaceutical PIN Points
- CPhI Japan Postponed